Feng Liu

机构：Shanghai Jiao Tong University, Kunming Medical University, Ruijin Hospital, Shanghai Institute of Hematology · ORCID：0000-0002-7589-2264

发表论文 29 篇 · 总被引 981 次 · h-index 15

代表论文

• Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment (2022 · Nature Communications · 被引 139)
• Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified (2018 · Haematologica · 被引 97)
• Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling (2017 · npj Precision Oncology · 被引 78)
• Enhancer-Derived RNA: A Primer (2017 · Genomics Proteomics & Bioinformatics · 被引 67)
• PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion (2024 · Journal for ImmunoTherapy of Cancer · 被引 58)
• Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations (2022 · Cell Reports · 被引 38)